Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study
Authors
Keywords
Qatar, SARS CoV 2, Virus testing, Respiratory infections, Epidemiology, Medical risk factors, Infectious disease epidemiology, Viral genome
Journal
PLOS MEDICINE
Volume 18, Issue 12, Pages e1003879
Publisher
Public Library of Science (PLoS)
Online
2021-12-17
DOI
10.1371/journal.pmed.1003879
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK
- (2021) Louis du Plessis et al. SCIENCE
- Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021
- (2021) Summer E. Galloway et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
- (2021) Pengfei Wang et al. NATURE
- Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
- (2021) Nicholas G. Davies et al. SCIENCE
- Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study
- (2021) Robert Challen et al. BMJ-British Medical Journal
- Mathematical modeling of the SARS-CoV-2 epidemic in Qatar and its impact on the national response to COVID-19
- (2021) Houssein H Ayoub et al. Journal of Global Health
- Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021
- (2021) Tjede Funk et al. Eurosurveillance
- Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
- (2021) Delphine Planas et al. NATURE MEDICINE
- Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants
- (2021) Laith J. Abu-Raddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic
- (2021) Laith J. Abu-Raddad et al. Scientific Reports
- SARS-CoV-2 infection is at herd immunity in the majority segment of the population of Qatar
- (2021) Mohamed H Al-Thani et al. Open Forum Infectious Diseases
- Real-Time SARS-CoV-2 Genotyping by High-Throughput Multiplex PCR Reveals the Epidemiology of the Variants of Concern in Qatar
- (2021) Mohammad R. Hasan et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar
- (2021) Hiam Chemaitelly et al. NATURE MEDICINE
- COVID-19 (SARS-CoV-2) outbreak monitoring using wastewater-based epidemiology in Qatar
- (2021) Jayaprakash Saththasivam et al. SCIENCE OF THE TOTAL ENVIRONMENT
- SARS-CoV-2 infection hospitalization, severity, criticality, and fatality rates in Qatar
- (2021) Shaheen Seedat et al. Scientific Reports
- SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals
- (2021) Peter V. Coyle et al. iScience
- A Systematic Review of the Protective Effect of Prior SARS-CoV-2 Infection on Repeat Infection
- (2021) N. Kojima et al. EVALUATION & THE HEALTH PROFESSIONS
- Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar
- (2021) Hiam Chemaitelly et al. NEW ENGLAND JOURNAL OF MEDICINE
- One Year of SARS-CoV-2: Genomic Characterization of COVID-19 Outbreak in Qatar
- (2021) Fatiha M. Benslimane et al. Frontiers in Cellular and Infection Microbiology
- Interpreting Diagnostic Tests for SARS-CoV-2
- (2020) Nandini Sethuraman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020
- (2020) Anika Singanayagam et al. Eurosurveillance
- Age could be driving variable SARS-CoV-2 epidemic trajectories worldwide
- (2020) Houssein H. Ayoub et al. PLoS One
- Epidemiological investigation of the first 5685 cases of SARS-CoV-2 infection in Qatar, 28 February–18 April 2020
- (2020) Hanan M Al Kuwari et al. BMJ Open
- Prolonged presence of viral nucleic acid in clinically recovered COVID-19 patients was not associated with effective infectiousness
- (2020) Ke Hong et al. Emerging Microbes & Infections
- Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting
- (2020) Laith J Abu-Raddad et al. CLINICAL INFECTIOUS DISEASES
- A meta-analysis on the role of children in SARS-CoV-2 in household transmission clusters
- (2020) Yanshan Zhu et al. CLINICAL INFECTIOUS DISEASES
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Covid-19: New coronavirus variant is identified in UK
- (2020) Jacqui Wise BMJ-British Medical Journal
- Two prolonged viremic SARS-CoV-2 infections with conserved viral genome for two months
- (2020) Laith J. Abu-Raddad et al. INFECTION GENETICS AND EVOLUTION
- Using the Standardized Difference to Compare the Prevalence of a Binary Variable Between Two Groups in Observational Research
- (2009) Peter C. Austin COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now